Conduent Integrates GenAI to Advance Reportable Event Detection
Conduent Incorporated (Nasdaq: CNDT), a global provider of technology-driven business solutions and services, has introduced a new GenAI-based system designed to transform how reportable events are identified and managed. The innovation sets a new benchmark for compliance with U.S. Food and Drug Administration (FDA) reporting standards.
Enhancing Compliance with AI
Powered by Microsoft Azure OpenAI, the solution automates the detection of reportable events for pharmaceutical and life sciences organizations. It analyzes data from all customer communication channels to ensure faster and more accurate reporting while reducing manual workloads and compliance risks.
“This AI capability elevates the quality and speed of regulatory event detection while setting a new compliance standard across the industry,” said a Conduent representative.
Contact Information
- Media: Sean Collins – +1-310-497-9205, [email protected]
- Investor Relations: Joshua Overholt – [email protected]
Author’s summary: Conduent’s new GenAI solution, powered by Azure OpenAI, redefines regulatory event detection in pharma, ensuring seamless FDA compliance through automation.